Early-Morning Hyperglycemia & Diabetic Ketoacidosis

Early-Morning Glycemic Swings

• Goal of diabetes management: keep blood glucose (BG) within a stable range; avoid oscillations between hyper- and hypoglycemia.
• Two distinct acute increases in BG that typically appear "overnight / first thing in the morning": Dawn Phenomenon & Somogyi Effect (Rebound Hyperglycemia).
• Knowing the difference is crucial because the underlying cause dictates opposite treatments.

Dawn Phenomenon

• Timing: Early-morning hours (pre-dawn to just after waking).
• Physiologic Trigger: Nocturnal surge of counter-regulatory hormones meant to "wake you up":
  • Growth hormone (GH)
  • Glucagon
  • Epinephrine / catecholamines
• Pathophysiology: Hormonal surge → hepatic gluconeogenesis + glycogenolysis → BG rises. Diabetic patient lacks sufficient endogenous insulin (been fasting 6–8 h) ⇒ cannot transport the glucose intracellularly ⇒ morning hyperglycemia.
• Clinical presentation: Patient feels "crappy"/ill upon waking; poor carbohydrate tolerance at breakfast.
• Treatment logic:
  • Provide insulin coverage that is peaking at dawn, e.g. intermediate-acting (NPH) or long-acting (glargine, detemir) administered bedtime.
  • Avoid short/rapid-acting insulin at bedtime; would peak too early (during sleep) and risk nocturnal hypoglycemia.

Somogyi Effect (True Rebound Hyperglycemia)

• Mnemonic: "Somogyi has two O’s → ‘Oh no! BG got too lOw’".
• Root Cause: Excess exogenous insulin (dose or timing) given at night.
  • $\text{Excess Insulin} \rightarrow \text{Hypoglycemia (↓BG)}$
• Counter-regulation: Body detects low BG → releases glucagon, epinephrine, cortisol, GH → hepatic glucose release → overshoot → early-morning hyperglycemia.
• Management options:
  1. Reduce night-time insulin dose or switch to a different type.
  2. Introduce a complex carbohydrate snack at bedtime to provide a slow, sustained glucose supply (prevents overnight BG nadir).

Quick Comparison

• Dawn Phenomenon: Hormonal surge → ↑BG; needs more/longer insulin at night.
• Somogyi: Excess insulin → ↓BG → counter-regulation → ↑BG; needs less insulin or bedtime snack.

Memory Devices

• Dawn → "Greet the dawn" hormones push BG up.
• Somogyi → "Oh-no low" (two O’s): overnight BG falls first.

Diabetic Ketoacidosis (DKA)

Trigger & Etiology

• Common precipitants: infection, acute illness, missed insulin, stress.
• Pathway (Flow-chart logic):
  1. Hyperglycemia ++ lack of effective insulin.
  2. Cells cannot utilize glucose.
  3. Body switches to fat/protein catabolism for energy.
  4. Lipolysis → free fatty acids → hepatic conversion → ketone bodies (acetoacetate, $\beta$-hydroxybutyrate, acetone).
  5. Ketones are acidic ⇒ metabolic acidosis.

Key Features

• 3 classic biochemical hallmarks: $\text{Hyperglycemia} + \text{Ketosis} + \text{Acidosis}$.
• Typical BG often >$250\,\text{mg/dL}$.
• Serum pH <$7.35$; HCO$_3^-$ low.

Clinical Manifestations

• Polyuria → dehydration → hypotension & tachycardia.
• Polydipsia (extreme thirst) – renal glucose & ketone osmotic diuresis.
• Kussmaul respirations: deep, rapid breathing to blow off $CO_2$ (acid) + excrete volatile acetone.
• "Fruity/rotten fruit" breath odor (acetone).
• Nausea, vomiting, abdominal pain (GI irritation from acidosis).
• Altered mental status → lethargy → coma if untreated.

Laboratory/Electrolyte Dynamics

• Urine ketones: $\text{Normal}=0$ → spill large amounts during DKA.
• Potassium shift:
  • Initial stage: lack of insulin + acidosis → $K^+$ moves from intracellular → extracellular → serum hyperkalemia.
  • During treatment: IV insulin drives glucose and $K^+$ back into cells → risk of hypokalemia.

Nursing Alert

• "When BG is high, $K^+$ is high; as BG drops, $K^+$ drops." Continuous ECG & electrolyte monitoring mandatory.

Treatment Overview

1. IV Insulin Drip (regular insulin)
   • On infusion pump only; never gravity drip.
   • Dose calculated from hospital-specific insulin calculator using real-time BG & electrolytes.
2. Fluid Resuscitation
   • Start with isotonic saline → switch to 0.45 % or add dextrose once BG <$250$ to avoid hypoglycemia.
3. Electrolyte Management
   • Monitor $K^+$ hourly; replace when levels fall or anticipate drop (often add $20–40\,\text{mEq}$ KCl to IVF once urine output adequate).
4. Acidosis Correction
   • Primarily via insulin; IV sodium bicarbonate considered if pH <$7.0$ and unresponsive.
5. Frequent Monitoring
   • Hourly BG checks; serial ABGs, electrolytes.

Potential Complications

• Hypoglycemia if insulin titrated too aggressively.
• Hypokalemia → dysrhythmias.
• Fluid overload (late phase) if resuscitation overshoots, especially in renal/cardiac patients.

Post-Crisis Education & Prevention

• Identify/resolve precipitating factors (infection control, adherence, sick-day rules).
• Teach home ketone testing (urine dipstick when BG >$240$ or during illness).
• Reinforce difference between Dawn vs Somogyi to adjust bedtime insulin/snacks.

Ethical & Practical Considerations

• DKA is life-threatening; rapid identification & treatment align with nursing ethical principle of beneficence.
• Precise insulin dosing prevents iatrogenic harm (non-maleficence).
• Patient autonomy enhanced by education on self-monitoring and prevention strategies.

Connections to Previous Lessons

• Links to prior lecture on metabolic acidosis (DKA classic cause).
• Reinforces acid–base compensatory mechanisms (Kussmaul respirations).
• Highlights role of insulin as "key" to cellular glucose uptake (foundational endocrine physiology).

Key Numbers & Equations (LaTeX format)

• Normal urine ketones: $0\,\text{mg/dL}$.
• Hyperglycemia in DKA: BG >$250\,\text{mg/dL}$ (often 350–800).
• Serum pH diagnostic: pH < 7.35 (severe if <$7.0$).
• Potassium range: $3.5–5.0\,\text{mEq/L}$ (watch for swings above 5.5 then below 3.5).
• Simplified treatment relationship: $\Delta K^+ \propto \Delta BG\; \text{(same direction)}$ during therapy.

Quick Study Checklist

• Differentiate Dawn vs Somogyi (cause & fix).
• Recognize DKA triad & classic signs (Kussmaul, fruity breath).
• Understand potassium shifts and cardiac monitoring.
• Recall stepwise DKA therapy: insulin drip, fluids, electrolytes, pH.
• Apply ethical principles by ensuring precise insulin administration & patient education.